Free Daily Biotech Industry Newsletter
Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 105,000 biotech professionals who subscribe to FierceBiotech for FREE!
With clinical trials now so expensive, partly driven by costly drug failures at a late stage, effective and efficient phase IIa trials are becoming more and more important in making early go/no go decisions. Join this live event to hear expert opinions on designing an effective phase IIa proof-of-concept study, what triggers a go/no-go decision at phase IIa and making the most of phase IIa data in dealmaking and collaboration. Register today!
FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 100,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!